Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows

v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities    
Net income (loss) $ (10,303) $ 180,789
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 514,972 488,027
Gain on derivatives (1,903) (1,129)
Loss on extinguishment of debt 117,938 29,000
Provision for bad debts and inventory obsolescence 2,152 3,198
Gain on involuntary conversion of assets 5 (4,462)
Share-based compensation expense 46,180 44,932
Net foreign currency adjustments on euro-denominated debt 137,922 (8,587)
Changes in operating assets and liabilities:    
Accounts receivable, net (46,754) 66,671
Inventories (11,319) 7,329
Prepaid expenses and other assets (89,441) (124,287)
Accounts payable 12,415 (2,216)
Accrued expenses and other liabilities 14,073 56,439
Advance ticket sales 708,135 742,360
Net cash provided by operating activities 1,394,072 1,478,064
Cash flows from investing activities    
Additions to property and equipment, net (1,858,861) (599,505)
Acquisition, net of cash acquired   (27,322)
Other (9,201) 5,955
Net cash used in investing activities (1,868,062) (620,872)
Cash flows from financing activities    
Repayments of long-term debt (3,866,296) (778,109)
Proceeds from long-term debt 4,452,990 261,734
Common share issuance proceeds, net 63,996  
Net share settlement of restricted share units (23,805) (22,039)
Early redemption premium (106,108) (19,163)
Deferred financing fees (53,537) (107,932)
Net cash provided by (used in) financing activities 467,240 (665,509)
Net increase (decrease) in cash and cash equivalents (6,750) 191,683
Cash and cash equivalents at beginning of period 190,765 402,415
Cash and cash equivalents at end of period $ 184,015 $ 594,098